LYON, France, Sept. 19 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP - News), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in Germany and an operations update at its recently formed German subsidiary. The DGU Conference begins September 20 in Hamburg and is the largest annual gathering of the German urology community with over 7,000 participants. EDAP is the largest provider of HIFU for localized prostate cancer, which is reimbursed under the German health plan, and continues to grow treatments at approximately 100 percent compared to the prior year. The company is presently adding marketing and education resources to further accelerate its growth to meet the expanding market opportunity in Germany.
